机器学习模型CoDE-ACS与指南推荐路径诊断心肌梗死的比较
本研究在5国12中心纳入4105例疑似非ST段抬高心肌梗死患者,于0、1、2小时连续检测高敏肌钙蛋白I,评估机器学习工具CoDE-ACS在不同时间点的诊断效能,并与ESC 0/1小时、ESC 0/2小时及High-STEACS路径比较。CoDE-ACS在各时间点表现一致,可识别更多低概率患者且阴性预测值达99.7%,与指南路径效能相当。
要点
- CoDE-ACS在0、1、2小时均可稳定识别低概率患者,阴性预测值99.7%。
- 首诊时CoDE-ACS识别56%低概率患者,多于ESC 0小时和High-STEACS路径。
- 加入1或2小时肌钙蛋白后,CoDE-ACS低概率比例升至65%或68%。
核心结论
- CoDE-ACS在不同连续肌钙蛋白检测时间点表现一致,能以与指南推荐路径相当的效能识别更多低概率心肌梗死患者。
研究设计与样本
- 多中心前瞻性队列研究,纳入5国12中心4105例疑似非ST段抬高心肌梗死患者,连续检测高敏肌钙蛋白I。
主要发现
- 共575例(14%)发生1型心肌梗死,患者平均年龄61岁,女性占32%。
- 首诊时CoDE-ACS识别56%低概率患者,阴性预测值99.7%(95%CI 99.5%-99.9%),灵敏度99.0%(98.6%-99.2%)。
- 1或2小时CoDE-ACS识别65%或68%低概率患者,阴性预测值均为99.7%(99.5%-99.9%)。
- 1或2小时CoDE-ACS识别19%或18%高概率患者,阳性预测值64.9%(63.5%-66.4%)和68.8%(67.3%-70.1%)。
- ESC 0/1小时、ESC 0/2小时和High-STEACS路径分别识别49%、53%、71%低风险患者,阴性预测值100%、100%、99.7%。
关键数值与推荐
- CoDE-ACS低概率阈值对应阴性预测值99.7%(95%CI 99.5%-99.9%),高概率阈值对应阳性预测值64.9%–68.8%。
- ESC 0/1小时和0/2小时路径低风险阴性预测值均为100%(99.9%-100%),High-STEACS为99.7%(99.5%-99.8%)。
- ESC 0/1小时、ESC 0/2小时和High-STEACS路径高概率阳性预测值分别为61.5%、65.8%、48.3%。
临床怎么用
- CoDE-ACS可在0、1、2小时任一连续肌钙蛋白检测时间点计算心肌梗死概率,辅助急诊分诊。
- 低概率患者可考虑早期排除心肌梗死,高概率患者需进一步评估,中间概率患者需留观。
局限性
- CoDE-ACS指导诊疗能否改善心肌梗死早期诊断尚需前瞻性评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Collaboration for the Diagnosis and Evaluation of Acute Coronary Syndrome (CoDE-ACS) is a validated clinical decision support tool that uses machine learning with or without serial cardiac troponin measurements at a flexible time point to calculate the probability of myocardial infarction (MI). How CoDE-ACS performs at different time points for serial measurement and compares with guideline-recommended diagnostic pathways that rely on fixed thresholds and time points is uncertain. METHODS: Patients with possible MI without ST-segment-elevation were enrolled at 12 sites in 5 countries and underwent serial high-sensitivity cardiac troponin I concentration measurement at 0, 1, and 2 hours. Diagnostic performance of the CoDE-ACS model at each time point was determined for index type 1 MI and the effectiveness of previously validated low- and high-probability scores compared with guideline-recommended European Society of Cardiology (ESC) 0/1-hour, ESC 0/2-hour, and High-STEACS (High-Sensitivity Troponin in the Evaluation of Patients With Suspected Acute Coronary Syndrome) pathways. RESULTS: In total, 4105 patients (mean age, 61 years [interquartile range, 50-74]; 32% women) were included, among whom 575 (14%) had type 1 MI. At presentation, CoDE-ACS identified 56% of patients as low probability, with a negative predictive value and sensitivity of 99.7% (95% CI, 99.5%-99.9%) and 99.0% (98.6%-99.2%), ruling out more patients than the ESC 0-hour and High-STEACS (25% and 35%) pathways. Incorporating a second cardiac troponin measurement, CoDE-ACS identified 65% or 68% of patients as low probability at 1 or 2 hours, for an identical negative predictive value of 99.7% (99.5%-99.9%); 19% or 18% as high probability, with a positive predictive value of 64.9% (63.5%-66.4%) and 68.8% (67.3%-70.1%); and 16% or 14% as intermediate probability. In comparison, after serial measurements, the ESC 0/1-hour, ESC 0/2-hour, and High-STEACS pathways identified 49%, 53%, and 71% of patients as low risk, with a negative predictive value of 100% (99.9%-100%), 100% (99.9%-100%), and 99.7% (99.5%-99.8%); and 20%, 19%, or 29% as high risk, with a positive predictive value of 61.5% (60.0%-63.0%), 65.8% (64.3%-67.2%), and 48.3% (46.8%-49.8%), resulting in 31%, 28%, or 0%, who require further observation in the emergency department, respectively. CONCLUSIONS: CoDE-ACS performs consistently irrespective of the timing of serial cardiac troponin measurement, identifying more patients as low probability with comparable performance to guideline-recommended pathways for MI. Whether care guided by probabilities can improve the early diagnosis of MI requires prospective evaluation. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT00470587.
引用
- Boeddinghaus, Doudesis, Lopez-Ayala, et al. Machine Learning for Myocardial Infarction Compared With Guideline-Recommended Diagnostic Pathways. Circulation. 2024. PMID: 38344871. doi:10.1161/CIRCULATIONAHA.123.066917
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。